Foria Review – A Real Study, and What Its Design Cannot Show

What Foria Is and Who It Is For

Foria sells intimate and menstrual wellness products containing CBD. Its best-known item is Relief Melts — vaginal suppositories containing 100mg of broad-spectrum CBD, marketed for menstrual pain, at around $72 for eight. It also sells Intimacy Melts and Awaken arousal and intimacy oils in organic coconut oil bases.

What makes this brand genuinely different from the dozen-plus CBD companies we have reviewed is that it has commissioned actual published research on its own product. That deserves serious treatment — both for what it found and for what its design can and cannot establish. Those two things occupy most of this review.

The Study: What It Found

Start with the credit, because it is substantial and almost unique in this category.

Put this in context. The overwhelming majority of CBD products have no research behind them at all — not a trial, not an observational study, nothing but testimonials. Commissioning research, submitting it to peer review, and publishing it in a Nature portfolio journal with academic collaborators is a materially higher standard than this industry operates at, and it should be said clearly before the criticisms.

The dose-dependent pattern is the most interesting single finding, because a dose-response relationship is one of the classic indicators that an effect may be real rather than incidental. It is not proof, but it is the kind of detail that makes a result more credible.

The Study: What Its Design Cannot Show

Now the other half, which the coverage of this research generally omits. Helpfully, the study’s own title tells you most of it.

The placebo problem is the serious one, and it is not a technicality. Pain is among the most placebo-responsive outcomes in all of medicine, and menstrual pain trials specifically show large placebo responses. When participants know they are using a novel product they sought out and paid for, expectation alone can produce substantial reported improvement.

Self-selection compounds it. The 77 women using suppositories chose to, and the 230 comparison participants were using conventional painkillers. Those are not equivalent groups — people who seek out a novel remedy differ systematically from those who reach for ibuprofen, in expectations, in how they have experienced conventional treatment, and probably in what they are willing to report.

And the funding matters. Industry funding does not make research invalid — a great deal of legitimate medical research is industry funded, and disclosure is the appropriate remedy. But it is a factor to weigh, particularly when the study design already leaves room for expectation effects.

So Does It Work?

What would settle it is a randomised, double-blind, placebo-controlled trial — identical suppositories with and without CBD, allocated at random, with nobody knowing which they received. That study has not been done. Until it is, “clinically proven” is not an available claim for this product, and you should treat any marketing that implies otherwise with care.

There is a practical point buried here that is worth stating plainly. If a product relieves your pain, it relieved your pain — placebo effects are real experiences, not imaginary ones, and for a symptom as subjective as cramping the distinction may matter less to you than it does to a researcher. What it should affect is how much you are willing to pay, and that brings us to $9 a dose.

The Latex Warning, Which They Handle Well

This is the most important practical safety point about the intimacy oils, and Foria deserves credit for the way it discloses it.

That last clause is why we are crediting them rather than criticising them. It would be easy to say “use lambskin” and stop, leaving people to discover the STI gap themselves. Spelling out that lambskin covers one risk and not the other is the responsible version, and it is more than several intimacy brands manage.

The instruction for readers is simple: if you rely on latex condoms for contraception or infection prevention, do not use an oil-based product with them. Switch to polyurethane, or use a water-based lubricant instead for those occasions.

Essential Oils on Mucosal Tissue

The Awaken with Organic Botanicals formula contains organic MCT coconut oil infused with kava root, cinnamon, ginger and vanilla, plus essential oils of cardamom, peppermint and cacao absolute. The ingredients are organic and food-grade, which is genuinely better than the alternative — but organic is not the same as non-irritating.

Practical protocol: patch test on a small area of inner forearm and wait, use a small amount the first time, and stop if there is burning rather than assuming it will settle. If you have a history of contact dermatitis, sensitive skin, recurrent thrush or bacterial vaginosis, speak to a clinician before using anything intravaginally.

Credit where due: Foria offers a CBD-free botanical version for people allergic or sensitive to CBD or hemp. Offering a version without your headline active ingredient is a thoughtful thing to do and not commercially obvious.

Pricing: $9 a Dose

At 100mg per suppository, $9 works out at about 9 cents per milligram of CBD — the most expensive per-milligram figure of any CBD product we have priced. That comparison is only partly fair, since a formulated suppository is not a tincture and the manufacturing is different. But it does mean you are paying a substantial premium for the format and the research, not for the cannabinoid.

The annual figure is the one worth confronting. $216 to $324 a year is a real commitment for symptom relief whose mechanism has not been separated from placebo. If it works for you, that may be money well spent. But given the evidence position, we would buy one pack and see rather than committing to a subscription.

There is a service discounts programme; we could not establish who qualifies.

When Period Pain Needs a Doctor, Not a Product

This is the most important section for anyone who arrived here searching for relief from severe cramps, and no affiliate commission is worth omitting it.

Use symptom relief alongside getting a diagnosis, not instead of it. If you have been managing severe period pain for years without investigation, the most valuable thing on this page is not a product recommendation — it is the suggestion to book an appointment and describe the pain honestly, including how much of your life it costs you.

Who Should Not Use These

• Anyone pregnant or trying to conceive, without clinical advice.
• Anyone relying on latex condoms for contraception or STI prevention — see above.
• Anyone with a history of sensitivity to essential oils, or recurrent thrush or bacterial vaginosis, without speaking to a clinician.
• Anyone taking medication metabolised through liver cytochrome P450 enzymes — CBD can interact, and this is a question for a prescriber.
• Anyone subject to drug testing — these are broad-spectrum products with lower risk, but no seller can guarantee a test result.
• Anyone with undiagnosed pelvic pain, abnormal bleeding, or pain during intercourse, who should be assessed first.

None of these products is FDA-approved to diagnose, treat, cure or prevent any condition, and no outcome is guaranteed.

How It Compares

The useful comparison is on evidence quality, since that is what Foria is genuinely competing on.

Foria sits second on that ladder, which is a genuinely good position in this category — well above the testimonial tier that most CBD brands occupy, and below the randomised controlled standard that a product we reviewed earlier in this series actually achieved. That is the honest placement.

Pros and Cons

Who Should Buy, and Who Should Not

Consider it if you have had menstrual pain properly assessed, conventional options have not suited you, and you want to try something with more evidence behind it than the rest of this category offers. Buy one pack rather than subscribing — at $9 a dose and with the evidence at the stage it is, a single trial tells you what you need to know.

Do not buy it instead of seeing a doctor. If severe period pain has never been investigated, that appointment matters far more than this product, and effective relief can quietly delay a diagnosis worth having.

Do not use the oils with latex condoms, and look elsewhere if you have sensitive or reactive tissue — the essential oil content makes these a poor first choice for anyone prone to irritation, though the CBD-free botanical option does not solve that since the botanicals are the irritant risk.

Limitations of This Review

We have not used any Foria product. Our assessment of the research is based on published reporting of the study rather than a reading of the full paper, so our characterisation of its methods, sample and limitations could be incomplete — anyone relying on this should read the paper itself, which is published and findable.

Specific gaps: we did not establish third-party testing arrangements or COA availability, which for a product used internally is a real omission on our part and worth checking yourself. We could not establish return terms, subscription pricing, or service discount eligibility. Prices are as reported and may have changed. We did not verify the CBD-free formulation’s full ingredient list.

Our comments on irritation potential reflect general properties of the named botanicals rather than reports about these specific products, and we found no body of complaints alleging harm. Our comments on placebo response reflect well-established features of pain research, not a claim that these findings are placebo. None of this is medical advice — any concern about menstrual pain, pelvic pain or intimate health belongs with a clinician.

Frequently Asked Questions

Verdict

Foria did something almost nobody in this industry does: it commissioned research on its own product, worked with academic researchers, submitted it to peer review and published it. Seventy-seven women, two cycles, a dose-dependent pattern, and over 80% reporting moderate to significant improvement. Against a category whose typical evidence base is a wall of five-star quotes, that is a real achievement and we would rather encourage it than punish it.

But the study’s own title contains the limitation. “Survey-based” means self-reported. “Quasi-experimental” means unrandomised. There was no placebo arm and no blinding, in an outcome — pain, and menstrual pain specifically — where placebo responses are famously large. The participants chose the product, and the company that makes it paid for the research. That combination cannot separate the CBD from the expectation, and until a randomised double-blind trial does, “clinically proven” is not available here.

Elsewhere the brand behaves well. The latex disclosure is accurate and unusually complete — including the detail that lambskin covers pregnancy but not infection, which plenty of brands leave out. Ingredients are organic and food-grade, and offering a CBD-free version for people who react to hemp is a considerate thing to do. The essential oils are the one formulation caveat: cinnamon and peppermint on mucosal tissue warrant a patch test, and the intended warming sensation makes early irritation harder to spot.

What holds the score at 3.8 is price against evidence. Nine dollars a dose, and $216 to $324 a year at regular use, is a lot for relief that has not been separated from placebo — which is why our recommendation is to buy a single pack, not a subscription. And if severe period pain has never been properly investigated, the appointment matters more than the product.